TG Therapeutics
TGTX
63.34
-1.54
-2.37%
TG Therapeutics
US · TGTX
#1638 by market cap
Listed 1970
63.34
-1.54
-2.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 6 analysts
Buy
Avg price target 76.40 +20.6%
Price target rangecurrent 63.34
Low71.00
Avg76.40
High86.00
Buy 83%
Hold 0%
Sell 17%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-10 | BofA Securities | -- | Sell | -- |
| 2026-11-10 | Evercore | -- | Buy | 71.00 |
| 2026-11-09 | TD Cowen | -- | Buy | 75.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | 72.00 |
| 2026-10-25 | J.P. Morgan | -- | Buy | -- |
| 2026-09-21 | H.C. Wainwright | -- | Buy | 78.00 |
| 2026-09-02 | B. Riley Securities | -- | Buy | 86.00 |
| 2026-09-01 | H.C. Wainwright | -- | Buy | 78.00 |
| 2026-08-10 | J.P. Morgan | -- | Buy | 72.00 |
| 2026-08-05 | BofA Securities | -- | Sell | 21.00 |
| 2026-08-04 | H.C. Wainwright | -- | Buy | 78.00 |
| 2026-08-03 | TD Cowen | -- | Buy | 75.00 |
| 2026-08-03 | H.C. Wainwright | -- | Buy | 78.00 |
| 2026-07-20 | TD Cowen | -- | Buy | 75.00 |
| 2026-07-16 | J.P. Morgan | -- | Buy | 65.00 |
| 2026-07-14 | Jefferies | -- | Buy | 83.00 |
| 2026-07-13 | H.C. Wainwright | -- | Buy | 77.00 |
| 2026-07-07 | BofA Securities | -- | Sell | 20.00 |
| 2026-07-06 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-06-21 | Jefferies | -- | Buy | 83.00 |
| 2026-06-09 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-06-04 | BofA Securities | -- | Sell | 17.00 |
| 2026-06-04 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-06-03 | Goldman Sachs | -- | Hold | 41.00 |
| 2026-06-03 | H.C. Wainwright | -- | Buy | 70.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-09 | -- | ±10.18% | +5.94% (in line) |
| 2026/Q2 | 2026-08-03 | -- | ±11.70% | -11.26% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±8.84% | +16.26% (beat) |
| 2025/Q4 | 2026-02-26 | -- | ±10.46% | +4.18% (in line) |
| 2025/Q3 | 2025-11-03 | -- | ±14.48% | -3.13% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±14.55% | -17.99% (beat) |
| 2025/Q1 | 2025-05-05 | -- | ±13.78% | -13.26% (in line) |
| 2024/Q4 | 2025-03-03 | -- | ±13.16% | +14.39% (beat) |
| 2024/Q3 | 2024-11-04 | -- | ±17.85% | -9.44% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±23.03% | +19.58% (in line) |
| 2024/Q1 | 2024-05-01 | -- | ±8.76% | +16.25% (beat) |
| 2023/Q4 | 2024-02-28 | -- | ±17.58% | +26.74% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.
TG Therapeutics discussion 0 comments